| Bioactivity | HBV Seq2 aa:208-216, a HBsAg derived CD8 epitope peptide, is studied as part of Large envelope protein from Hepatitis B virus[1]. |
| Invitro | HBV Seq2 aa:208-216 是乙型肝炎病毒（人类乙型肝炎病毒）的大包膜蛋白的一部分[1]。 |
| Name | HBV Seq2 aa:208-216 |
| CAS | 160214-63-1 |
| Sequence | Ile-Leu-Ser-Pro-Phe-Leu-Pro-Leu-Leu |
| Shortening | ILSPFLPLL |
| Formula | C52H85N9O11 |
| Molar Mass | 1012.29 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
HBV Seq2 aa:208-216
CAS: 160214-63-1 F: C52H85N9O11 W: 1012.29
HBV Seq2 aa:208-216, a HBsAg derived CD8 epitope peptide, is studied as part of Large envelope protein from Hepatitis B
Data collection：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.